ImmuCell CEO Michael Brigham plans retirement by early 2026; board launches succession search

IMMUCELL CORP /DE/

President/CEO Michael Brigham (65) intends to retire from full-time work by early 2026; board has started successor search.
Brigham's prior CFO responsibilities transferred to recently hired CFO Timothy C. Fiori.
Goal to identify new CEO candidate by around year-end 2025; Brigham will stay until transition complete.
Brigham to remain on board through term ending June 2026 and beyond, subject to stockholder vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.